Paralyzed with the Frustration of Pediatric Sedation
Of the pediatric patients that are admitted to an intensive care unit, more than 40% of these admissions require mechanical ventilation. In the pediatric intensive care unit (PICU), appropriate monitoring and use of agents for sedation and paralysis is vital, especially in patients who require mechanical ventilation. This CE presentation will educate pharmacists on the most up-to-date, evidence-based, guideline-recommended approach to sedation, paralysis, and delirium in the PICU.
Upon completion of this activity, the participant will be able to:
- Recognize appropriate agents used for sedation in patients admitted to the PICU.
- Identify appropriate agents used for paralysis in patients admitted to the PICU based on patient-specific factors.
- Describe pharmacologic strategies used to avoid or minimize delirium in pediatric patients admitted to the PICU.
Hailey Chapdelaine, PharmD, is a PGY1 Pharmacy Resident at Baystate Medical Center in Springfield, MA. Hailey earned her PharmD at the University of Rhode Island in Kingston, RI. Hailey’s practice interests include pediatrics and critical care.
Registration Fee: This module is provided free of charge.
Release Date: June 14, 2022
Expiration Date: June 14, 2023
ACPE UAN: 0026-0000-22-133-H01-P | Knowledge
ACPE Topic Designator: Disease State Management/Drug Therapy
Contact Hours: 1.0 (0.1 CEU)
Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Massachusetts College of Pharmacy and Health Sciences designates this activity for a total of 1 contact hour (0.1 CEUs).
In order to receive credit, the participant must view the entire presentation and complete the pre and post-tests, and evaluation form. Upon completion, participant credit will be reported to CPE Monitor. Transcripts may be printed from CPE Monitor.
The policy of Massachusetts College of Pharmacy and Health Sciences is ensuring balance, independence, objectivity, and scientific rigor in all of its educational activities. Any individuals involved in planning or content creation for a continuing education activity are required to disclose financial relationships with ineligible companies that have occurred within the last 24 months. The intent of the policy is to identify and mitigate potential conflicts of interest that may affect the activity. All clinical medicine recommendations must be based on evidence accepted within the medical profession.
Hailey Chapdelaine has no relevant financial relationships with ineligible companies to disclose.
Residency Director Frank Szczerba has no relevant financial relationships with ineligible companies to disclose.
Massachusetts College of Pharmacy and Health Sciences Continuing Education staff members hold no financial relationships with ineligible companies related to the content of this presentation.
Massachusetts College of Pharmacy and Health Sciences will identify, review, and mitigate all conflicts of interest disclosed prior to delivery of an educational activity to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation, but provides participants with information that may be of potential importance when they are evaluating content.